CDK Global Appoints Brian P. MacDonald as Chief Executive Officer
Mar 08, 2016 21:19 pm UTC| Business
HOFFMAN ESTATES, Ill., March 08, 2016 -- The Board of Directors of CDK Global, Inc.(Nasdaq:CDK) (“CDK” or the “Company”) today announced that, consistent with the transition plan announced on December 11, 2015, Steven...
Mar 08, 2016 21:15 pm UTC| Business
HUNTINGTON BEACH, Calif., March 08, 2016 -- BJ's Restaurants, Inc. (Nasdaq:BJRI) announced today that Greg Trojan, President and Chief Executive Officer and Greg Levin, Executive Vice President and Chief Financial...
Mercury Systems Receives $2.2M Order for Signals Intelligence Application
Mar 08, 2016 21:15 pm UTC| Business
CHELMSFORD, Mass., March 08, 2016 -- Mercury Systems, Inc. (NASDAQ:MRCY) (www.mrcy.com), announced today that it received a $2.2 million order from a leading systems integrator to supply high-performance digital signal...
Ramco-Gershenson Properties Trust Refinances $60 Million Unsecured Term Loan
Mar 08, 2016 21:15 pm UTC| Business
FARMINGTON HILLS, Mich., March 08, 2016 -- Ramco-Gershenson Properties Trust (NYSE:RPT) (the “Company”) today announced that it has entered into an agreement to extend its $60 million unsecured term loan with an...
Mar 08, 2016 21:15 pm UTC| Business
STEVENSON, Md., March 08, 2016 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the...
Cempra to Participate in Nature's Webcast on Combating Antibiotic Resistance on March 9
Mar 08, 2016 21:10 pm UTC| Business
CHAPEL HILL, N.C., March 08, 2016 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious...
Galectin Therapeutics to Hold Business Update Conference Call on March 15
Mar 08, 2016 21:09 pm UTC| Business
NORCROSS, Ga., March 08, 2016 -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announces that in conjunction with the filing...